Phaarmasia P/B Ratio
Phaarmasia (PHRMASI) P/B ratio is 2.72 (Moderate), book value per share ₹31.43 vs Healthcare average P/B of -0.01 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see PHRMASI share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PHRMASI P/B Ratio — Valuation Insights & Book Value Analysis
Phaarmasia price-to-book ratio interpretation, valuation status and historical context — current P/B 2.72 (Moderate). Read PHRMASI dividend track record for the complete payout history and dividend yield track record.
- Current PB is 28.8% below historical average
- Trading at premium to sector average PB of -0.01
Phaarmasia P/B Ratio Historical Trend
PHRMASI annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore PHRMASI value investing to estimate fundamental worth using multiple valuation models.
PHRMASI Historical P/B Ratio — Book Value Per Share & Year-End Price
Phaarmasia annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.8 | ₹31.43 | ₹88.00 | ₹22 | Moderate |
| 2025 | 8.77 | ₹12.86 | ₹112.74 | ₹9 | High |
| 2024 | 3.4 | ₹14.29 | ₹48.50 | ₹10 | High |
| 2023 | 2.51 | ₹15.71 | ₹39.37 | ₹11 | Moderate |
| 2022 | 1.62 | ₹17.14 | ₹27.85 | ₹12 | Moderate |
PHRMASI vs Healthcare Peers — P/B Ratio Comparison
Phaarmasia P/B 2.72 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |